We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODV
801
DELISTED
ModivCare
MODV
| $24K | ﹤0.01% |
+171
| New | +$21.2K |
|
802
Movado Group
MOV
$866M
| $24K | ﹤0.01% |
+1,456
| New | +$20.8K |
|
803
REX American Resources
REX
$1.42B
| $24K | ﹤0.01% |
+1,938
| New | +$25.4K |
|
804
Global X Silver Miners ETF NEW
SIL
$4.07B
| $24K | ﹤0.01% |
+541
| New | +$23.7K |
|
805
Tennant Co
TNC
$1.46B
| $24K | ﹤0.01% |
+340
| New | +$22.3K |
|
806
Dentsply Sirona
XRAY
$2.83B
| $24K | ﹤0.01% |
+450
| New | +$22.2K |
|
|
CXO
807
DELISTED
CONCHO RESOURCES INC.
CXO
| $24K | ﹤0.01% |
+419
| New | +$22.1K |
|
|
BEAT
808
DELISTED
BioTelemetry, Inc.
BEAT
| $24K | ﹤0.01% |
+333
| New | +$17.4K |
|
809
Air Products & Chemicals
APD
$65.2B
| $23K | ﹤0.01% |
+83
| New | +$23.4K |
|
810
Astec Industries
ASTE
$1.21B
| $23K | ﹤0.01% |
+389
| New | +$22.2K |
|
811
Cboe Global Markets
CBOE
$31.2B
| $23K | ﹤0.01% |
+247
| New | +$21.6K |
|
812
Cohu
COHU
$2.3B
| $23K | ﹤0.01% |
+593
| New | +$16.2K |
|
813
Corcept Therapeutics
CORT
$12.2B
| $23K | ﹤0.01% |
+868
| New | +$18.3K |
|
814
FormFactor
FORM
$8.48B
| $23K | ﹤0.01% |
+526
| New | +$19K |
|
815
The GEO Group
GEO
$4.19B
| $23K | ﹤0.01% |
+2,626
| New | +$25.2K |
|
816
Kontoor Brands
KTB
$4.68B
| $23K | ﹤0.01% |
+565
| New | +$20.8K |
|
817
Linde
LIN
$222B
| $23K | ﹤0.01% |
+89
| New | +$21.8K |
|
818
MarketAxess Holdings
MKTX
$5.71B
| $23K | ﹤0.01% |
+40
| New | +$21.8K |
|
|
MPT
819
Medical Properties Trust
MPT
$2.75B
| $23K | ﹤0.01% |
+1,059
| New | +$20.6K |
|
820
Pacira BioSciences
PCRX
$1.06B
| $23K | ﹤0.01% |
+378
| New | +$22.1K |
|
821
iShares TIPS Bond ETF
TIP
$14.5B
| $23K | ﹤0.01% |
+188
| New | +$23.7K |
|
822
Visa
V
$683B
| $23K | ﹤0.01% |
+104
| New | +$21.3K |
|
823
Vanda Pharmaceuticals
VNDA
$315M
| $23K | ﹤0.01% |
+1,724
| New | +$20.8K |
|
824
Wabash National
WNC
$508M
| $23K | ﹤0.01% |
+1,311
| New | +$21.2K |
|
|
EGRX
825
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $23K | ﹤0.01% |
+485
| New | +$22.7K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.